CN101528181A - 制造医用纳米颗粒悬浮液的方法 - Google Patents
制造医用纳米颗粒悬浮液的方法 Download PDFInfo
- Publication number
- CN101528181A CN101528181A CNA2007800261476A CN200780026147A CN101528181A CN 101528181 A CN101528181 A CN 101528181A CN A2007800261476 A CNA2007800261476 A CN A2007800261476A CN 200780026147 A CN200780026147 A CN 200780026147A CN 101528181 A CN101528181 A CN 101528181A
- Authority
- CN
- China
- Prior art keywords
- active ingredient
- laser
- aaerosol solution
- laser irradiation
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000006185 dispersion Substances 0.000 title claims description 23
- 239000003814 drug Substances 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims abstract description 22
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims description 77
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 238000011275 oncology therapy Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 230000000202 analgesic effect Effects 0.000 claims description 5
- 229940035676 analgesics Drugs 0.000 claims description 5
- 239000000730 antalgic agent Substances 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 4
- 239000000725 suspension Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 19
- 239000008187 granular material Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 13
- 239000002245 particle Substances 0.000 description 10
- ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 9
- SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 9
- 239000011859 microparticle Substances 0.000 description 8
- 230000000857 drug effect Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 238000009434 installation Methods 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000010414 supernatant solution Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000013081 microcrystal Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000006061 abrasive grain Substances 0.000 description 2
- 239000002269 analeptic agent Substances 0.000 description 2
- 230000003555 analeptic effect Effects 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- -1 argon ion Chemical class 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003741 agents affecting lipid metabolism Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- YDTFRJLNMPSCFM-YDALLXLXSA-M levothyroxine sodium anhydrous Chemical compound [Na+].IC1=CC(C[C@H](N)C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 YDTFRJLNMPSCFM-YDALLXLXSA-M 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/10—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing sonic or ultrasonic vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
- B01J19/121—Coherent waves, e.g. laser beams
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0881—Two or more materials
- B01J2219/089—Liquid-solid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Electromagnetism (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Colloid Chemistry (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006135878A JP2007306950A (ja) | 2006-05-15 | 2006-05-15 | 薬効成分ナノ粒子分散液の製造方法 |
JP135878/2006 | 2006-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101528181A true CN101528181A (zh) | 2009-09-09 |
Family
ID=38693918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800261476A Pending CN101528181A (zh) | 2006-05-15 | 2007-05-15 | 制造医用纳米颗粒悬浮液的方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7597278B2 (zh) |
EP (1) | EP2033616A4 (zh) |
JP (1) | JP2007306950A (zh) |
CN (1) | CN101528181A (zh) |
WO (1) | WO2007132828A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890164A (zh) * | 2010-02-10 | 2010-11-24 | 上海蓝怡科技有限公司 | 激光制备纳米药物制剂的方法 |
CN102802934A (zh) * | 2010-02-10 | 2012-11-28 | 亿目朗美国股份有限公司 | 利用高重复率的超快脉冲激光烧蚀在液体中生产有机化合物纳米颗粒 |
CN108057406A (zh) * | 2017-12-14 | 2018-05-22 | 中国科学院长春光学精密机械与物理研究所 | 一种酞菁纳米材料及其制备方法 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005051511A1 (ja) * | 2003-11-28 | 2005-06-09 | Mitsubishi Chemical Corporation | 有機化合物微粒子の製造方法 |
JP5436821B2 (ja) * | 2008-09-03 | 2014-03-05 | 国立大学法人 琉球大学 | ナノ粒子の生成・吐出器具 |
US20110033545A1 (en) * | 2009-08-06 | 2011-02-10 | Absize, Inc. | Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
JP5677409B2 (ja) * | 2010-03-11 | 2015-02-25 | 浜松ホトニクス株式会社 | 微粒子分散液製造方法および微粒子分散液製造装置 |
JP2015506986A (ja) | 2012-02-13 | 2015-03-05 | イムラ アメリカ インコーポレイテッド | 液中パルスレーザーアブレーションによって製造された非晶質医薬微粒子およびその製造方法 |
JP5406962B2 (ja) * | 2012-06-14 | 2014-02-05 | 花王株式会社 | ナノ粒子の製造方法 |
DE102013205462A1 (de) * | 2013-03-27 | 2014-10-02 | Freie Universität Berlin | Verfahren zur infrarotlichtinduzierten Ausbeuteoptimierung von chemischen Reaktionen durch Schwingungsanregung |
CN108079919B (zh) * | 2017-12-20 | 2019-11-19 | 长春微纪元科技有限公司 | 高精度全自动纳米材料合成系统 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
JP4457439B2 (ja) * | 1999-10-14 | 2010-04-28 | Dic株式会社 | 有機化合物の微粒子の製造方法 |
JP2003518038A (ja) | 1999-12-20 | 2003-06-03 | ニコラス, ジェイ カークホフ, | 流動床噴霧乾燥によるナノ粒子製造方法 |
JP4293586B2 (ja) * | 2002-08-30 | 2009-07-08 | 浜松ホトニクス株式会社 | ナノ粒子の製造方法及び製造装置 |
JP4116404B2 (ja) | 2002-11-18 | 2008-07-09 | 浜松ホトニクス株式会社 | ナノ粒子化処理に用いるレーザ光照射条件の決定方法及び決定装置並びにナノ粒子の製造方法 |
JP4344153B2 (ja) * | 2003-03-07 | 2009-10-14 | 浜松ホトニクス株式会社 | 微粒子の製造方法及び製造装置、並びに注射剤の製造方法 |
WO2004080586A1 (ja) * | 2003-03-07 | 2004-09-23 | Hamamatsu Photonics K.K. | 微粒子、その製造方法及び製造装置、並びに注射剤及びその製造方法 |
EP1632225A4 (en) | 2003-06-11 | 2007-08-15 | Nara Machinery Co Ltd | DRUG NANOPARTICLE, PROCESS AND APPARATUS FOR PREPARING PHARMACEUTICAL PREPARATION THEREFROM |
JP4287727B2 (ja) | 2003-10-22 | 2009-07-01 | 浜松ホトニクス株式会社 | 微粒子の製造方法、及び製造装置 |
JP2005125258A (ja) | 2003-10-24 | 2005-05-19 | Hamamatsu Photonics Kk | 微粒子、微粒子の製造方法、及び製造装置 |
EP1685905A4 (en) | 2003-11-20 | 2009-09-09 | Hamamatsu Photonics Kk | MICRO PARTICLES, METHOD FOR THE PRODUCTION OF MICROPARTICLES AND MANUFACTURING DEVICE |
JP4482322B2 (ja) * | 2003-12-18 | 2010-06-16 | 浜松ホトニクス株式会社 | 微粒子の製造方法、及び製造装置 |
JP4643155B2 (ja) | 2004-02-24 | 2011-03-02 | 株式会社ABsize | 薬効成分の超微粒子の製造方法 |
JP4398280B2 (ja) | 2004-02-26 | 2010-01-13 | 浜松ホトニクス株式会社 | 微粒子の製造方法 |
JP4593144B2 (ja) | 2004-03-26 | 2010-12-08 | 浜松ホトニクス株式会社 | 微粒子化条件の決定方法、決定装置、及び微粒子の製造方法、製造装置 |
JP4717376B2 (ja) | 2004-05-27 | 2011-07-06 | 浜松ホトニクス株式会社 | 微粒子の製造方法、及び製造装置 |
JP4408245B2 (ja) * | 2004-07-14 | 2010-02-03 | 浜松ホトニクス株式会社 | 微粒子の製造方法、及び製造装置 |
JP4142675B2 (ja) | 2005-08-10 | 2008-09-03 | 株式会社ABsize | フラーレン分散液の製造方法 |
-
2006
- 2006-05-15 JP JP2006135878A patent/JP2007306950A/ja active Pending
-
2007
- 2007-05-15 WO PCT/JP2007/059913 patent/WO2007132828A1/ja active Search and Examination
- 2007-05-15 CN CNA2007800261476A patent/CN101528181A/zh active Pending
- 2007-05-15 EP EP07743348A patent/EP2033616A4/en not_active Withdrawn
- 2007-05-15 US US11/798,621 patent/US7597278B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890164A (zh) * | 2010-02-10 | 2010-11-24 | 上海蓝怡科技有限公司 | 激光制备纳米药物制剂的方法 |
CN102802934A (zh) * | 2010-02-10 | 2012-11-28 | 亿目朗美国股份有限公司 | 利用高重复率的超快脉冲激光烧蚀在液体中生产有机化合物纳米颗粒 |
CN108057406A (zh) * | 2017-12-14 | 2018-05-22 | 中国科学院长春光学精密机械与物理研究所 | 一种酞菁纳米材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US7597278B2 (en) | 2009-10-06 |
US20080237376A1 (en) | 2008-10-02 |
EP2033616A1 (en) | 2009-03-11 |
WO2007132828A1 (ja) | 2007-11-22 |
EP2033616A4 (en) | 2010-03-03 |
JP2007306950A (ja) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101528181A (zh) | 制造医用纳米颗粒悬浮液的方法 | |
Date et al. | Current strategies for engineering drug nanoparticles | |
CN1148169C (zh) | 通过溶于压缩气体和表面活性剂制备(亚)微米级粒子的方法 | |
Wang et al. | Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells | |
KR20060052849A (ko) | 약물 초미립자의 제조 방법 및 제조 장치 | |
Muller et al. | Nanosuspensions: a formulation approach for poorly soluble and poorly bioavailable drugs | |
US20060255323A1 (en) | Process for producing fine particles of organic compound | |
KR20020037027A (ko) | 초정밀 마이크로입자 및 나노입자의 완만한 제조 방법 | |
JPH07165562A (ja) | 表面を修飾された抗癌性ナノ粒子 | |
KR100603974B1 (ko) | 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법 | |
SK284541B6 (sk) | Spôsob výroby nosiča liečiva, ktorý obsahuje častice čistej účinnej látky, nerozpustné alebo málo rozpustné vo vode, a nosič liečiva | |
JP2001113159A (ja) | 有機化合物の微粒子の製造方法 | |
EP2013138B1 (en) | Method for preparing nano-scale particle of active material | |
US20180344645A1 (en) | Prepartion of nanocrystals and nanaoparticles of narrow distribution and uses thereof | |
CN102350280B (zh) | 具有超声波振动装置的静电液滴发生装置及应用其制备载药凝胶微球的方法 | |
JP4204634B2 (ja) | 難水溶性医薬 | |
Utekhina et al. | Organic nanoparticles | |
Shah | Use of nanotechnologies for drug delivery | |
KR101342119B1 (ko) | 디올 화합물을 이용한 나노수준의 활성물질 입자 제조 방법 | |
JP2010234218A (ja) | 有機化合物ナノ粒子分散液の製造方法及び製造装置 | |
CN101416946B (zh) | 采用振动磨技术制备可生物降解的植入控释微球及其制法 | |
KR101342121B1 (ko) | 저온 및 저압 하에서 초임계유체를 이용한 나노수준의활성물질 입자 제조방법 | |
JP2009119379A (ja) | 液中レーザーアブレーション用デバイスおよび液中レーザーアブレーションシステム | |
AU2013206706B2 (en) | Method for preparing nano-scale particle of active material | |
EP3962464B1 (en) | Process for preparing nanoparticles in the form of a powder comprising a bio-resorbable polyester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ELLY SCIENCE AND TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: NATIONAL UNIVERSITY CORPORATION OSAKA UNIVERSITY Effective date: 20091030 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20091030 Address after: Osaka Applicant after: Univ Osaka Address before: Osaka, Japan Applicant before: Osaka University, National University Co-applicant before: Univ Osaka |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1135015 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090909 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1135015 Country of ref document: HK |